Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Vertex Inks RNA Splicing Pact With Skyhawk

Paying $40m Upfront

Dec 22 2020

• By Kevin Grogan

Business Growth Concept_1089895325_1200.jpg — Vertex looking to grow business beyond cystic fibrosis • Source: Shutterstock

Related Content

Deal Watch: Genentech Inks New Collaborations With Skyhawk, Convelo

Jul 16 2019

New CRISPR Therapeutics/Vertex Data Dangle The Hope Of Cure For SCD and TDT

Dec 07 2020

Moderna Expands Horizons With Vertex and Chiesi Deals

Sep 17 2020

Deal Watch: Another Delay For Roche/Spark, While FTC Ups AbbVie/Allergan Merger Scrutiny

Oct 03 2019

Related Companies

Vertex Pharmaceuticals Incorporated

Skyhawk Therapeutics, Inc.

Merck & Co., Inc.

Roche Holding AG

Moderna, Inc.

Ribometrix, Inc.

CRISPR Therapeutics AG

Additional Topics

Deals Companies Strategy Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.